Si bien ese resultado es coherente con el concepto de continuidad teraputica en intervenciones incretnicas, en Mxico la indicacin aprobada es control glucmico en diabetes tipo 2, y cualquier extrapolacin a otras metas debe alinearse a regulacin y guas clnicas locales. En el ensayo SURMOUNT4 (fase 3, aleatorizado, retirada), tras 36 semanas iniciales con tirzepatida, quienes continuaron el frmaco mantuvieron y aumentaron la prdida de peso en las 52 semanas siguientes, mientras que quienes cambiaron a placebo recuperaron una fraccin relevante del peso perdido
Some people have questioned the validity of the photos, as it appears n3glv has two different eye colors in the photographs The drug n3glv claims to use, Melanotan-II, has not been approved by government agencies
Kablinger, Carilion Clinic, director of clinical research, Department of Psychiatry and Behavioral Medicine, Virginia Tech Carilion School of Medicine The late Warren K
Am J Physiol Gastrointest Liver Physiol 2012
Nonetheless, the magnitude of weight reduction observed at higher doses is notable given that achieving substantial weight loss in individuals with type 2 diabetes has historically been more difficult than in those with obesity alone, partly due to the metabolic effects of the condition itself and certain antidiabetic medications
